Relapsing Nephrotic Syndrome Complicated by Hypokalemia and Urinary Tract Infection: A Case Report
DOI:
https://doi.org/10.37287/ijghr.v8i4.1877Keywords:
hypokalemia, relapsing nephrotic syndrome, urinary tract infectionAbstract
Relapse in adult nephrotic syndrome represents a clinically complex phase characterized not only by recurrent proteinuria but also by heightened vulnerability to metabolic and infectious complications. A 24-year-old male with a prior history of nephrotic syndrome presented with generalized edema, foamy urine, and dysuria. Urinalysis showed 3+ proteinuria, while laboratory evaluation revealed severe hypoalbuminemia (1.1 g/dL) and hypokalemia (2.9 mmol/L) with bacteriuria. A diagnosis of relapsing nephrotic syndrome complicated by moderate hypokalemia and urinary tract infection was established. The patient received step-down intravenous methylprednisolone, ceftriaxone, 20% albumin infusion, combined furosemide–spironolactone therapy, and cautious intravenous potassium replacement under continuous ECG monitoring. Within seven days, edema improved significantly and serum potassium normalized without complications. Infection-triggered relapse may worsen electrolyte imbalance through urinary losses and diuretic therapy. Early identification of hypokalemia and infection is essential to prevent cardiac and renal complications. Coordinated pharmacologic management allows safe correction while maintaining fluid balance. Prompt recognition and multidisciplinary management of relapse-associated infection and electrolyte disturbance are critical to improving outcomes in adult nephrotic syndrome.
References
Azukaitis, K., Palmer, S. C., Strippoli, G. F., & Hodson, E. M. (2022). Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database Syst Rev, 3(3). https://doi.org/10.1002/14651858.CD001537.pub5.www.cochranelibrary.com
Busuioc, R. M., & Mircescu, G. (2022). Nephrotic Syndrome Complications – New and Old. Part 1. Maedica (Bucur), 17(1), 153–168.
Castro, D., & Sharma, S. (2025). Hypokalemia. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482465/
Chang, C.-H., Yu, H.-J., & Hou, Y.-C. (2023). The exacerbated hypokalemia in membranous glomerulonephritis due to proximal tubular injury: a neglect issue from a case report and literature review. BMC Nephrology, 24(1), 98.
Clase, C. M., Carrero, J. J., Ellison, D. H., Grams, M. E., Hemmelgarn, B. R., Jardine, M. J., Kovesdy, C. P., Kline, G. A., Lindner, G., Obrador, G. T., Palmer, B. F., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., Pecoits-Filho, R., Ashuntantang, G. E., Bakker, S. J. L., Bakris, G. L., Bhandari, S., … Wingo, C. S. (2020). Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 97(1), 42–61. https://doi.org/10.1016/j.kint.2019.09.018
Culver, S. A., Suleman, N., Kavuru, V., & Siragy, H. M. (2024). Renal Hypokalemia: An Endocrine Perspective. The Journal of Clinical Endocrinology & Metabolism, 109(7), 1694–1706.
EAU Guidelines Office. (2023). EAU Guidelines on Urological Infections. European Association of Urology.
Ellison, D. H., & Felker, G. M. (2017). Diuretic Treatment in Heart Failure. N Engl J Med, 377(20), 1964–1975.
Faucon, A.-L., Lando, S., Chrysostomou, C., Wijkstrom, J., Lundberg, S., Bellocco, R., Segelmark, M., Evans, M., & Carrero, J.-J. (2025). Primary glomerular diseases and long-term adverse health outcomes: A nationwide cohort study. Journal of Internal Medicine, 297(1), 22–35.
Fratila, V. G., Lupușoru, G., Sorohan, B. M., Obrișcă, B., Mocanu, V., Lupușoru, M., & Ismail, G. (2024). Nephrotic Syndrome: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines, 12(3), 1–21. https://doi.org/10.3390/biomedicines12030569
Garg, P. (2018). A Review of Podocyte Biology. Am J Nephrol, 47(Suppl 1), 3–13.
Kardalas, E., Kardalas, E., Paschou, S. A., Anagnostis, P., Muscogiuri, G., & Siasos, G. (2018). Hypokalemia : a clinical update. Endocr Connect, 7(4), 135–146.
KDIGO Blood Pressure Work Group. (2021). KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney International, 99(3), S1–S87.
Kopp, J. B., Anders, H.-J., Susztak, K., Podesta, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020). Podocytopathies. Nat Rev Dis Primers, 6(1).
McMahon, R. S., & Bashir, K. (2023). Pottasium Chloride. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557785/
Patibandla, S., Heaton, J., & Kyaw, H. (2023). Spironolactone. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554421/
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., Jayne, D. R. W., Jha, V., Liew, A., Liu, Z. H., Mejía-Vilet, J. M., Nester, C. M., Radhakrishnan, J., Rave, E. M., Reich, H. N., … Floege, J. (2021). KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International, 100(4), S1–S276. https://doi.org/10.1016/j.kint.2021.05.021
Tapia, C., & Bashir, K. (2023). Nephrotic Syndrome. Nephrotic Syndrome. https://www.ncbi.nlm.nih.gov/books/NBK470444/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Indonesian Journal of Global Health Research

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.








